SERA PROGNOSTICS INC-A
SERA · NASDAQ
Updated at 2026-10-15 05:47:30
- Today's High
- $2.07
- Today’s Low
- $2.03
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.03
- Previous Close
- $2.07
- Volume
- 5.83K
- Market Cap
- $81.66M
- P/E Ratio
- --
- EPS
- $-0.66
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 2749 EAST PARLEYS WAY, SALT LAKE CITY, UT, UNITED STATES, 84109
- Country
- US
- Listing Date
- 2021-07-15
- Fiscal Year End
- December
- Shares Outstanding
- 39.16M
- CIK
- 0001534969
- Website
- www.sera.com
Sera Prognostics Inc. is a pioneering force in maternal-fetal health, focusing on cutting-edge diagnostic solutions designed to enhance pregnancy outcomes. Its flagship product, the PreTRM test, harnesses a unique biomarker platform to accurately evaluate the risk of preterm birth, enabling healthcare providers to implement timely and impactful interventions. With a steadfast commitment to advancing prenatal diagnostics and addressing pivotal health challenges, Sera is strategically positioned for significant growth within the maternal health sector, offering investors compelling opportunities for long-term value creation.
Financial Metrics
Revenue
2026-06-30
$30K
2026-03-31
$14K
2025-12-31
$10K
2025-09-30
$16K
Operating Expenses
2026-06-30
$9.98M
2026-03-31
$9.33M
2025-12-31
$8.92M
2025-09-30
$8.95M
Net Income
2026-06-30
-$9.13M
2026-03-31
-$8.39M
2025-12-31
-$7.88M
2025-09-30
-$7.81M
Net Profit Margin
2026-06-30
-30.46K%
2026-03-31
-59.99K%
2025-12-31
-78.81K%
2025-09-30
-48.83K%
Earnings Per Share
2026-06-30
$-0.18
2026-03-31
$-0.17
2025-12-31
$-0.16
2025-09-30
$-0.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$8.94M
2026-03-31
-$8.2M
2025-12-31
-$7.63M
2025-09-30
-$7.56M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $30K | $14K | $10K | $16K |
| Operating Expenses | $9.98M | $9.33M | $8.92M | $8.95M |
| Net Income | -$9.13M | -$8.39M | -$7.88M | -$7.81M |
| Net Profit Margin | -30.46K% | -59.99K% | -78.81K% | -48.83K% |
| Earnings Per Share | $-0.18 | $-0.17 | $-0.16 | $-0.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$8.94M | -$8.2M | -$7.63M | -$7.56M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.